Core Insights - GE HealthCare (GEHC) reported second-quarter 2025 adjusted earnings per share (EPS) of $1.06, exceeding the Zacks Consensus Estimate of 91 cents by 16.5%, and showing a 6% year-over-year improvement [1][7] - The company raised its 2025 EPS forecast to a range of $4.43-$4.63, reflecting continued demand for its products and services [9][10] Revenue Details - GEHC reported revenues of $5 billion, a 3% increase year over year, with organic growth of 2%, surpassing the Zacks Consensus Estimate by 0.1% [2][7] - Total company orders increased 3% organically year over year, driven by strong performance in the U.S. market, particularly in Imaging and Pharmaceutical Diagnostics segments [2] Segmental Performance - **Imaging**: Revenues totaled $2.2 billion, up 2% year over year, with segment EBIT at $188 million, down 10% [3] - **Advanced Visualization Solutions**: Revenues reached $1.29 billion, a 3% increase year over year, with segment EBIT at $267 million, up 4% [3] - **Patient Care Solutions**: Revenues amounted to $778 million, a 1% increase year over year, with segment EBIT at $60 million, down 23% [4] - **Pharmaceutical Diagnostics**: Revenues totaled $729 million, up 14% year over year, with segment EBIT at $213 million, up 7% [4] Margins and Cash Flow - The net income margin was 9.7%, an increase of 80 basis points from the prior year, primarily due to productivity and pricing benefits [5] - Cumulative cash flow from operating activities at the end of the second quarter was $344 million, compared to $300 million a year ago [5] Financial Position - GEHC ended the second quarter with cash, cash equivalents, and investments of $3.76 billion, up from $2.47 billion in the previous quarter [8] - Total assets increased to $35.5 billion from $33.59 billion sequentially [8] 2025 Guidance - GE HealthCare raised its earnings and organic revenue guidance for 2025, now expecting adjusted EPS in the range of $4.43-$4.63, up from a previous range of $3.90-$4.10 [9][10] - The company anticipates organic revenue growth of 3%, an increase from the previously expected 2-3% [10]